Companion Diagnostic FDA Review Flexibilities: An Assessment of CDx for NSCLC to Support Aligned Approaches for Validation
Crossref DOI link: https://doi.org/10.1007/s43441-025-00799-7
Published Online: 2025-05-15
Published Print: 2025-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Andrews, Hillary S.
Collins, Grace
Navarro-Serer, Bernat
Stewart, Mark D.
Allen, Jeff D.
Text and Data Mining valid from 2025-05-15
Version of Record valid from 2025-05-15
Article History
Received: 6 February 2025
Accepted: 7 May 2025
First Online: 15 May 2025
Declarations
:
: The authors declare no competing interests.